Enhancing Health and Quality of Life for Individuals With Dementia Through Transitional-State Snacks

Sponsor
University of Oregon (Other)
Overall Status
Recruiting
CT.gov ID
NCT05007730
Collaborator
Oregon Health and Science University (Other), Oregon Partnership for Alzheimer's Research (Other)
50
2
1
15
25
1.7

Study Details

Study Description

Brief Summary

Malnutrition significantly contributes to the disability and mortality associated with Alzheimer's disease and Alzheimer's disease-related dementias. Thus, nutritional status is one important, modifiable clinical factor for maintaining physical and cognitive health among persons with dementia (PWD). This project will pilot an innovative approach to enhancing nutrition through the use of transitional-state snack supplements, or foods that start as one texture and change to another.

Specifically, this study aims to demonstrate the feasibility, acceptability, and safety of a transitional-state therapeutic nutrition supplement among adults with dementia. The central hypothesis is that access to ready-made, savory, nutrient- dense snack supplements that resemble "typical" preferred foods and eating habits will result in improved nutritional intake and status among PWD.

Condition or Disease Intervention/Treatment Phase
  • Dietary Supplement: Transitional-state food therapeutic nutrition supplement
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
50 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Enhancing Health and Quality of Life for Individuals With Dementia Through Transitional-State Snacks
Anticipated Study Start Date :
May 1, 2022
Anticipated Primary Completion Date :
Aug 1, 2023
Anticipated Study Completion Date :
Aug 1, 2023

Arms and Interventions

Arm Intervention/Treatment
Experimental: Intervention Arm

Dietary Supplement: Transitional-state food therapeutic nutrition supplement
Participants will consume at least one "snack-sized" package of the transitional-state food supplements per day across the intervention trial.

Outcome Measures

Primary Outcome Measures

  1. Participant enrollment rates (%) [Measured during recruitment (at baseline, prior to study onset; week 0)]

    The percentage of participants enrolled (i.e., who meet all eligibility criteria) as compared to the total number of participants who are recruited (i.e., initiate contact with the research team)

  2. Proportion of participants deemed eligible to consume transitional-state foods [Prior to enrollment (to determine eligibility at baseline, prior to study onset; week 0)]

    Instrumental swallowing assessments will be conducted for each participant by a licensed speech-language pathologist to determine whether the potential participant can safely consume transitional-state foods based on their swallowing physiology. The number of potential participants deemed eligible to consume this consistency of food will be compared to the total number of potential participants receiving the swallow study.

  3. Participant retention rates (%) [Measured at the end of the study (post-intervention, after 8 weeks of snack consumption)]

    The percentage of participants retained (i.e., who who remain enrolled and participate for the duration of the study) as compared to the total number of participants who are enrolled

  4. Change in acceptability of nutrition supplements [Measured weekly for enrolled participants (weeks 1, 2, 3, 4, 5, 6, 7, 8)]

    Using a Likert (5 point) rating scale, participants will rate their acceptability of the nutrition supplements each week. Change in acceptability will be calculated over the length of the study (e.g., increased or decreased acceptability over time)

  5. Number of test snacks consumed each week [Measured weekly for enrolled participants (weeks 1, 2, 3, 4, 5, 6, 7, 8)]

    As a measured of adherence to the protocol, participants will document the total number of test snacks consumed each week (protocol is for at least one snack per day)

Secondary Outcome Measures

  1. Change in malnutrition status (not present, present, moderate, severe) [Measured at baseline (study onset) and post-intervention (end of study after 8 weeks of snack consumption)]

    Malnutrition status (not present, present, moderate, severe) will be assessed via a nutrition-focused physical exam (NFPE) by a registered dietitian. The exams will be guided by the recommendations of the American Society for Parenteral and Enteral Nutrition (ASPEN) in conjunction with the Academy of Nutrition and Dietetics (AND) and use the following characteristics for diagnosing malnutrition: insufficient energy intake, weight loss, loss of muscle mass, loss of subcutaneous fat, fluid accumulation, and diminished functional status. Using published definitions of the six clinical characteristics, a diagnosis of severe malnutrition, moderate malnutrition, or not malnourished will be made.

  2. Change in malnutrition risk score [Measured at baseline (study onset) and post-intervention (end of study after 8 weeks of snack consumption)]

    A malnutrition risk score will be calculated using the Mini Nutritional Assessment-Short Form (MNA-SF). Using the information collected by a registered dietitian during a nutrition-focused physical exam, the MNA-SF will be scored; the MNA-SF is a six-item, validated, and reliable screening tool for malnutrition risk.

  3. Change in daily energy intake (kcal/d) [Baseline (study onset), mid-intervention (approximately 4 weeks into the trial), post-intervention (end of study after 8 weeks of snack consumption)]

    Daily energy intake (in kcal/d) will be calculated based on photo-assisted, 24-hour dietary recalls completed via telephone. Three recalls will take place over the course of 2 weeks for each time point of interest.

  4. Change in fat intake (g/d) [Baseline (study onset), mid-intervention (approximately 4 weeks into the trial), post-intervention (end of study after 8 weeks of snack consumption)]

    Daily fat intake (in g/d) will be calculated based on photo-assisted, 24-hour dietary recalls completed via telephone. Three recalls will take place over the course of 2 weeks for each time point of interest.

  5. Change in protein intake (g/d) [Baseline (study onset), mid-intervention (approximately 4 weeks into the trial), post-intervention (end of study after 8 weeks of snack consumption)]

    Daily protein intake (in g/d) will be calculated based on photo-assisted, 24-hour dietary recalls completed via telephone. Three recalls will take place over the course of 2 weeks for each time point of interest.

  6. Change in carbohydrate intake (g/d) [Baseline (study onset), mid-intervention (approximately 4 weeks into the trial), post-intervention (end of study after 8 weeks of snack consumption)]

    Daily carbohydrate intake (in g/d) will be calculated based on photo-assisted, 24-hour dietary recalls completed via telephone. Three recalls will take place over the course of 2 weeks for each time point of interest.

  7. Change in calcium intake (mg/d) [Baseline (study onset), mid-intervention (approximately 4 weeks into the trial), post-intervention (end of study after 8 weeks of snack consumption)]

    Daily calcium intake (in mg/d) will be calculated based on photo-assisted, 24-hour dietary recalls completed via telephone. Three recalls will take place over the course of 2 weeks for each time point of interest.

  8. Change in vitamin D intake (mg/d) [Baseline (study onset), mid-intervention (approximately 4 weeks into the trial), post-intervention (end of study after 8 weeks of snack consumption)]

    Daily vitamin D intake (in mg/d) will be calculated based on photo-assisted, 24-hour dietary recalls completed via telephone. Three recalls will take place over the course of 2 weeks for each time point of interest.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Medically stable

  • Community dwelling

  • Has a medical diagnosis of dementia or possible dementia

Exclusion Criteria:
  • Does not live at home

  • Cannot participate in the protocol independently and do not have a consistent caregiver who can provide assistance

  • Does not have smartphone access

  • Requires 100% feeding assistance

  • Is NPO (nil per os)

  • Has multiple food allergies

  • Requires a strict renal, low-fat, and/or no-salt diet

  • Is deemed unsafe for the transitional-state foods by a speech-language pathologist

Contacts and Locations

Locations

Site City State Country Postal Code
1 University of Oregon Eugene Oregon United States 97403
2 Oregon Health & Science University Portland Oregon United States 97239

Sponsors and Collaborators

  • University of Oregon
  • Oregon Health and Science University
  • Oregon Partnership for Alzheimer's Research

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
University of Oregon
ClinicalTrials.gov Identifier:
NCT05007730
Other Study ID Numbers:
  • 02042020.009
First Posted:
Aug 16, 2021
Last Update Posted:
Jun 1, 2022
Last Verified:
May 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by University of Oregon
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jun 1, 2022